180 related articles for article (PubMed ID: 7329486)
1. Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis.
Rubin J; Ray R; Barnes T; Bower J
Nephron; 1981; 29(3-4):124-7. PubMed ID: 7329486
[TBL] [Abstract][Full Text] [Related]
2. Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.
Wideröe TE; Smeby LC; Mjåland S; Dahl K; Berg KJ; Wessel Aas T
Nephron; 1984; 38(4):238-47. PubMed ID: 6514073
[TBL] [Abstract][Full Text] [Related]
3. Dialysate flow rate and peritoneal clearance.
Rubin J; Adair C; Barnes T; Bower J
Am J Kidney Dis; 1984 Nov; 4(3):260-7. PubMed ID: 6496469
[TBL] [Abstract][Full Text] [Related]
4. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
Hung SY; Chung HM
Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal dialysis during peritonitis.
Rubin J; McFarland S; Hellems EW; Bower JD
Kidney Int; 1981 Mar; 19(3):460-4. PubMed ID: 7241884
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.
Ortega O; Gallar P; Carreño A; Gutierrez M; Rodriguez I; Oliet A; Vigil A; Gimenez E
Am J Nephrol; 2001; 21(3):189-93. PubMed ID: 11423687
[TBL] [Abstract][Full Text] [Related]
7. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
Lin CY; Chen WP; Yang LY; Chen A; Huang TP
Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of continuous ambulatory peritoneal dialysis.
Rubin J; Kirchner K; Barnes T; Teal N; Ray R; Bower JD
Am J Kidney Dis; 1983 Nov; 3(3):199-204. PubMed ID: 6638015
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Petersen J; Stewart RD; Catto GR; Edward N
Nephron; 1985; 40(1):79-82. PubMed ID: 4000338
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of Staphylococcus epidermidis peritonitis in patients on dialysate containing 1.25 mmol/L calcium.
Piraino B; Bernardini J; Holley JL; Perlmutter JA
Am J Kidney Dis; 1992 Apr; 19(4):371-4. PubMed ID: 1562027
[TBL] [Abstract][Full Text] [Related]
11. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.
Mactier RA; Moore H; Khanna R; Shah J
Nephron; 1990; 54(3):240-4. PubMed ID: 2179758
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal clearances with different dialysis regimens in children undergoing continuous cycling peritoneal dialysis.
Leichter HE; Salusky IB; von Lilien T; Laidlaw S; Alliapoulos JC; Hall TL; Fine RN
Nephrol Dial Transplant; 1989; 4(10):893-9. PubMed ID: 2515495
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin absorption from the peritoneal cavity during dialysis-related peritonitis.
Rubin J
Perit Dial Int; 1990; 10(4):283-5. PubMed ID: 2096929
[TBL] [Abstract][Full Text] [Related]
14. Changes of surface tension of dialysate depending on its composition in continuous ambulatory peritoneal dialysis.
Jeleniewicz R; Majdan M; Buraczyńska K; Portala P; Majdan M
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):290-5. PubMed ID: 12898852
[TBL] [Abstract][Full Text] [Related]
15. Nitrogen losses and cephalothin absorption in peritonitis treated by hourly peritoneal dialysis.
Rubin J; Adair C
Am J Kidney Dis; 1988 Mar; 11(3):214-9. PubMed ID: 3344744
[TBL] [Abstract][Full Text] [Related]
16. Continuous ambulatory peritoneal dialysis.
Popovich RP; Moncrief JW; Nolph KD; Ghods AJ; Twardowski ZJ; Pyle WK
Ann Intern Med; 1978 Apr; 88(4):449-56. PubMed ID: 637423
[TBL] [Abstract][Full Text] [Related]
17. Peritonitis in children undergoing dialysis. 10 years experience.
Levy M; Balfe JW; Geary DF; Fryer-Keene SP; Bannatyne RM
Child Nephrol Urol; 1988-1989; 9(5):253-8. PubMed ID: 3271590
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
[TBL] [Abstract][Full Text] [Related]
19. Continuous ambulatory peritoneal dialysis - initial experience.
Watson AJ; Hillery M; Grant G; Stassen LF; Keogh JA
Ir Med J; 1981 Nov; 74(11):330-3. PubMed ID: 7309459
[No Abstract] [Full Text] [Related]
20. Cephalexin for the oral treatment of CAPD peritonitis.
Drew PJ; Casewell MW; Desai N; Houang ET; Simpson CN; Marsh FP
J Antimicrob Chemother; 1984 Feb; 13(2):153-9. PubMed ID: 6368518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
